200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 100490-36-6

100490-36-6

100490-36-6 | 1,8-Naphthyridine-3-carboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-

CAS No: 100490-36-6 Catalog No: AG00023Z MDL No:MFCD00865059

Product Description

Catalog Number:
AG00023Z
Chemical Name:
1,8-Naphthyridine-3-carboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-
CAS Number:
100490-36-6
Molecular Formula:
C19H15F3N4O3
Molecular Weight:
404.3426
MDL Number:
MFCD00865059
IUPAC Name:
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
InChI:
InChI=1S/C19H15F3N4O3/c20-9-1-2-15(13(21)5-9)26-8-12(19(28)29)16(27)11-6-14(22)18(24-17(11)26)25-4-3-10(23)7-25/h1-2,5-6,8,10H,3-4,7,23H2,(H,28,29)
InChI Key:
WUWFMDMBOJLQIV-UHFFFAOYSA-N
SMILES:
NC1CCN(C1)c1nc2n(cc(c(=O)c2cc1F)C(=O)O)c1ccc(cc1F)F

Properties

Complexity:
708  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
404.11g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
404.349g/mol
Monoisotopic Mass:
404.11g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
99.8A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.4  

Literature

Title Journal
In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines. Biocontrol science 20120601
Synthesis of acrylonitriles through an FeCl3-catalyzed domino propargylic substitution/aza-Meyer-Schuster rearrangement sequence. Chemistry (Weinheim an der Bergstrasse, Germany) 20120521
Rhabdomyolysis associated with antimicrobial drug-resistant Mycoplasma pneumoniae. Emerging infectious diseases 20120501
[Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibacterial agents in Gifu and Aichi prefecture (2008-2009)]. The Japanese journal of antibiotics 20120201
Toxic epidermal necrolysis associated with sorafenib and tosufloxacin in a patient with hepatocellular carcinoma. Annals of dermatology 20111201
[Intractable pediatric infectious disease: examining the ability of a new drug, tosufloxacin tosilate hydrate for pediatric (discussion)]. The Japanese journal of antibiotics 20111001
Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong. The Journal of antibiotics 20110801
Sitafloxacin: in bacterial infections. Drugs 20110416
[Validity of using imipenem as a representative carbapenems and levofloxacin as a representative fluoroquinolones in antibiotics susceptibility test for enterobacteriaceae]. The Japanese journal of antibiotics 20110201
In the quest of drugs for bad bugs: are newer fluoroquinolones any better? Journal of laboratory physicians 20110101
[Intractable pediatric infectious disease: examining the ability of a new drug, tosufloxacin tosilate hydrate for pediatric]. The Japanese journal of antibiotics 20101201
Risk factors for acute prostatitis after transrectal biopsy of the prostate. Korean journal of urology 20100601
[Epidemiological analysis of Streptococcus pneumoniae in Gifu prefecture]. The Japanese journal of antibiotics 20100601
[Antibiotic susceptibility of blood-borne Streptococcus pneumoniae and efficacy assessment of respiratory quinolones using Monte Carlo simulation]. The Japanese journal of antibiotics 20100201
Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines. Clinical ophthalmology (Auckland, N.Z.) 20100101
Legionella pneumophila induces cathepsin B-dependent necrotic cell death with releasing high mobility group box1 in macrophages. Respiratory research 20100101
[Efficacy of tosufloxacin in genital chlamydial infections]. The Japanese journal of antibiotics 20091001
Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis (Edinburgh, Scotland) 20090901
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents. Bioorganic & medicinal chemistry 20090801
Measurement of AQCmax of five different ophthalmic solutions and discussion of its new application. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801
Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery. Drugs 20090618
[Antibacterial activity of quinolones against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory]. The Japanese journal of antibiotics 20090601
Fluoroquinolones reduce carrageenan-induced edema in rats and the involvement of the glucocorticoid receptor system. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20090401
Functional characterization of multidrug and toxin extrusion protein 1 as a facilitative transporter for fluoroquinolones. The Journal of pharmacology and experimental therapeutics 20090201
Corneal deposits after topical tosufloxacin in a patient with poor tear secretion. Cornea 20090101
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents. Drug metabolism and pharmacokinetics 20090101
Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles. PloS one 20090101
[Sensitivity surveillance of Haemophilus influenzae isolates for several antibiotics in Gifu Prefecture (2006)]. The Japanese journal of antibiotics 20080801
Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin. International journal of urology : official journal of the Japanese Urological Association 20080701
Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. The British journal of ophthalmology 20080601
In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin. Eye & contact lens 20080301
Multidrug-resistant typhoid fever outbreak in travelers returning from Bangladesh. Emerging infectious diseases 20071201
Effect of GrlA mutation on the development of quinolone resistance in Staphylococcus aureus in an in vitro pharmacokinetic model. The Journal of antimicrobial chemotherapy 20071101
[A case of acute bronchitis caused by Neisseria meningitidis associated with HIV infection]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20071101
A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070801
[Effectiveness of switch therapy for peritonitis]. The Japanese journal of antibiotics 20070801
Tosufloxacin tosilate-induced thrombocytopenic purpura. The Journal of dermatology 20070701
[Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory infections]. The Japanese journal of antibiotics 20070401
[Susceptibility of clinical isolates from primary care clinics to oral antibacterial agents]. The Japanese journal of antibiotics 20070201
[Evaluation of efficacy of oral quinolone against Streptococcus pneumoniae AND Haemophilus influenzae with the use of Monte Carlo simulation]. The Japanese journal of antibiotics 20061201
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 20060801
Azithromycin failure in Mycoplasma genitalium urethritis. Emerging infectious diseases 20060701
Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory or otorhinological infections: comparison with the results obtained from organisms isolated about 10 years ago. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060601
[Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibiotics in Gifu prefecture (2004)]. The Japanese journal of antibiotics 20060601
In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus. International journal of antimicrobial agents 20060201
Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in vitro model simulating serum concentration. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060201
In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species. The Journal of antimicrobial chemotherapy 20051201
In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101
[Clinical experience of streptococcal balanoposthitis in 47 healthy adult males]. Hinyokika kiyo. Acta urologica Japonica 20051101
Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20051001
Antimicrobial safety: focus on fluoroquinolones. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715
Prevalence of Ile-460-Val/ParE substitution in clinical Streptococcus pneumoniae isolates that were less susceptible to fluoroquinolones. Current microbiology 20050701
Terbium sensitized determination of tosufloxacin using electrochemiluminescence method. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20050401
VapB-positive Rhodococcus equi infection in an HIV-infected patient in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20050201
[Study on the accumulation of fluoroquinolones in clinical isolates of susceptible and multi-drug-resistant Escherichia coli strains]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20050101
[Clinical study of male urethritis in Oogaki Municipal Hospital]. Hinyokika kiyo. Acta urologica Japonica 20050101
An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate. American journal of kidney diseases : the official journal of the National Kidney Foundation 20041101
[Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20040501
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Antimicrobial agents and chemotherapy 20040401
Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20040401
Anaphylaxis due to tosufloxacin tosilate. The Journal of dermatology 20030901
Alteration of constitutive apoptosis in neutrophils by quinolones. Inflammation 20030601
A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group. Journal of medicinal chemistry 20030508
[Salmonella infections]. Nihon rinsho. Japanese journal of clinical medicine 20030201
[Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae]. The Japanese journal of antibiotics 20030201
[The history of the development and changes of quinolone antibacterial agents]. Yakushigaku zasshi 20030101
[In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone]. The Japanese journal of antibiotics 20021201
In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates. Antimicrobial agents and chemotherapy 20020301
Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin. Clinical and experimental pharmacology & physiology 20020301
Pharmacokinetics and safety assessment of tosufloxacin tosilate. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301
Clinical assessment of tosufloxacin tosilate. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301
In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301
In vitro method for prediction of the phototoxic potentials of fluoroquinolones. Toxicology in vitro : an international journal published in association with BIBRA 20011201
Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20011201
A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia. Japanese journal of pharmacology 20011101
Pulmonary infiltration with eosinophilia (PIE) syndrome induced by antibiotics, PIPC and TFLX during cancer treatment. Oral oncology 20010701
[An adult case of systemic cat-scratch disease with hepatosplenic involvement]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20010601
Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20010301
Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20010301
Accumulation of ofloxacin and tosufloxacin in fluoroquinolone-resistant E coli. Acta pharmacologica Sinica 20010301
Quinolones alter defense reactions mediated by macrophages. International immunopharmacology 20010201
History of quinolones and their side effects. Chemotherapy 20010101
The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors. Medicinal research reviews 20000701
Dual inhibitory activity of sitafloxacin (DU-6859a) against DNA gyrase and topoisomerase IV of Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 19991001
Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice. Arzneimittel-Forschung 19961201
N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies. Antimicrobial agents and chemotherapy 19961101
Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Antimicrobial agents and chemotherapy 19961001
[In vitro anti-MAC activities of new quinolones in focus (2)]. Kekkaku : [Tuberculosis] 19960901
Trovafloxacin is active against Toxoplasma gondii. Antimicrobial agents and chemotherapy 19960801
In-vitro activity of quinolones and macrolides against mycobacteria. The Journal of antimicrobial chemotherapy 19940901
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990. The Journal of antimicrobial chemotherapy 19930401
Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids. Journal of medicinal chemistry 19920207
[Nephrotoxicity test on T-3262 in rats with experimental nephropathy]. The Japanese journal of antibiotics 19890401

© 2019 Angene International Limited. All rights Reserved.